Eurazeo SE — M&A Activity 2019

Mar 20, 2019

EURAZEO GROWTH RENEWS ITS SUPPORT FOR DOCTOLIB BY CONTRIBUTING TO ITS NEW FUNDRAISING

PARIS, March 20, 2019 - Eurazeo Growth, a Doctolib shareholder since November 2017, has contributed to the company's latest €150 million fundraising, organized with the investment fund General Atlantic and certain historical shareholders. Eurazeo Growth has invested a total of €55 million in Doctolib.

These funds will be used by the company to pursue its investments in France and Germany, boost the deployment of its teleconsultation service, further enhance its products and penetrate new countries.

Doctolib is Europe's leading online booking platform and web services provider for healthcare professionals. Since its creation in 2013, Doctolib has revolutionized the medical appointment booking process. The company proposes software for healthcare professionals to improve their organizational efficiency, transform the patient experience, promote their business and strengthen cooperation with fellow practitioners. Doctolib makes it easier for patients to find and contact healthcare professionals. They can also book appointments online 24/7 and conduct teleconsultations.

Yann du Rusquec, Managing Director of Eurazeo Growth declared: "In a few years, Doctolib has become the undisputed e-healthcare leader in Europe, thanks to the determination, ambition and audacity of its teams and their remarkable ability to deliver results. There are huge development possibilities in France and internationally and we're delighted to contribute to this new fundraising."

Stanislas Niox-Château, Chairman and co-founder of Doctolib, added: "Our priority is to invest in the team. We'll double in size in the next 3 years and we'll continue investing to ensure the personal development of our employees. We now have 750 employees with the same entrepreneurial frame of mind, the same enthusiasm for the healthcare system and the same devotion to the daily service that we provide to practitioners, secretaries and patients."

About Eurazeo

Eurazeo is a leading global investment company, with a diversified portfolio of €17 billion in assets under management, including nearly €11 billion from third parties, invested in over 300 companies. With its considerable private equity, venture capital, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its 235 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. Eurazeo has offices in Paris, New York, Sao Paulo, Buenos Aires, Shanghai, London, Luxembourg, Frankfurt and Madrid.

• o Eurazeo is listed on Euronext Paris.
• o ISIN: FR0000121121 Bloomberg: RF FP Reuters: EURA.PA

1

About Doctolib

Founded in 2013, Doctolib is the European e-healthcare leader. It proposes software and services for practitioners to improve their organizational efficiency, transform the patient experience, promote their business and strengthen cooperation with fellow healthcare professionals. Doctolib provides patients with easier and quicker access to healthcare by enabling them to find information on their healthcare professionals, book appointments online 24/7, conduct teleconsultations and access their history of consultations online. The company has 750 employees in 40 cities in France and Germany. It works with 75,000 healthcare professionals and 1,400 healthcare facilities. Doctolib records over 30 million patient visits per month. For further information, go directly to the website. www.doctolib.fr.

EURAZEO CONTACTS PRESS CONTACT

CAROLINE COHEN HEAD OF INVESTOR RELATIONS E-mail: ccohen@eurazeo.com Tel.: +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT HEAD OF COMMUNICATIONS E-mail: vchristnacht@eurazeo.com Tel.: +33 (0)1 44 15 76 44

HAVAS PARIS MAEL EVIN E-mail: mael.evin@havas.com Tel: +33 (0)6 44 12 14 91

For further information, please visit our website: www.eurazeo.com Follow us on Twitter, Linkedin, and YouTube

2